Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis

Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF) now has two licensed treatments available. Pirfenidone was the first drug to be licensed and approved for use, followed by nintedanib. We set out our real world experience with these agents in terms of their adverse events profile outside the restrictions of a cli...

Full description

Bibliographic Details
Main Authors: Gareth Hughes, Hannah Toellner, Helen Morris, Colm Leonard, Nazia Chaudhuri
Format: Article
Language:English
Published: MDPI AG 2016-09-01
Series:Journal of Clinical Medicine
Subjects:
pirfenidone
nintedanib
IPF
Idiopathic Pulmonary Fibrosis
Online Access:http://www.mdpi.com/2077-0383/5/9/78

Similar Items

Similar Items